Stocks discussed in the in-depth session of Jim Cramer’s Mad Money TV program, Thursday, December 20. Click on a stock ticker for more analysis:
Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round, Stop Trading and his Market Minute.
Rite Aid (RAD)
Commenting on a disappointing earnings report, Cramer admitted he made a mistake when he named RAD as his speculative stock of the year. When things are this bad, he added, they usually get worse, but he saluted CEO Mary Sammons' moral courage to appear on the show as planned in spite of Cramer's bearishness towards the retailer. "I believe that what we're doing is going to really reward Rite Aid shareholders," Sammons said, adding the Brooks Eckerd acquisition is going to be good in the long term, but will mean short-term losses. Sammons said Rite Aid could not have foreseen the bad economic conditions that currently prevail. Concerning the company's balance sheet, Sammons said sales will improve once its acquisition is integrated. Cramer told viewers to wait another quarter and to decide for themselves what they think about Rite Aid.
Cramer emphasized the importance of doing research on a stock – reading analysts report, SEC filings and conference calls – before investing. He recently researched Moog, and while he liked the jet producer's business, its industrial division, responsible for 46% of Moog's sales, lacks visibility. Cramer also discovered the company was not as diversified as he thought, and said though the aerospace play is cheap he is very hesitant to recommend it, and prefers Raytheon and Eaton. However, project-management and claims-consulting company Hill International may be a better bet, since it may make acquisitions with its $100 million and become the 12th instead of the 17th largest company in the sector. In addition, the company has strong international exposure and does not yet have an analyst covering it. However, currently Cramer would prefer to buy Foster Wheeler and Shaw Group rather than HINT.
Sell Block: Goldman Sachs (GS)
Cramer says Goldman is in a different breed from other financials and does not belong on his Sell Block. Before GS' quarter, Cramer was cautiously telling viewers simply to hold the stock, but now he thinks GS is a buy, not least because it has an edge in attracting sovereign investors with its strong prime brokerage business and stability. Cramer says GS is the only financial that is not hurting.
David Snow discussed the company's improving clinical outcomes and its therapeutic resource centers which ensure physicians have proper experience. In addition the MHS advises its customers and has strong generic dispensing rates. Finally, Snow said MHS would not change its guidance if UNH were to leave the company. Cramer would buy the stock.
Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.
Seeking Alpha is not affiliated with Jim Cramer, CNBC or TheStreet.com